History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease
In this issue of JAMA Dermatology, Becker et al1 report an extensive retrospective study of 300 patients who received diagnoses of IgA epidermolysis bullosa acquisita (EBA), IgG EBA, or linear IgA disease (LAD) at a single institution. They identified cohorts of 3 different autoimmune bullous diseas...
Gespeichert in:
Veröffentlicht in: | Archives of dermatology (1960) 2021-08, Vol.157 (8), p.907-909 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 909 |
---|---|
container_issue | 8 |
container_start_page | 907 |
container_title | Archives of dermatology (1960) |
container_volume | 157 |
creator | Hashimoto, Takashi Yamagami, Jun Zone, John J |
description | In this issue of JAMA Dermatology, Becker et al1 report an extensive retrospective study of 300 patients who received diagnoses of IgA epidermolysis bullosa acquisita (EBA), IgG EBA, or linear IgA disease (LAD) at a single institution. They identified cohorts of 3 different autoimmune bullous diseases (AIBDs), including 222 cases of lamina lucida (LL)-type LAD with IgA autoantibodies reactive with the epidermal side in indirect immunofluorescence (IIF) using 1M sodium chloride–split normal human skin (ssIIF), which they designate as linear IgA bullous dermatosis (LABD), 57 cases of classical EBA with IgG autoantibodies to type VII collagen (COL7), and 21 cases of sublamina densa (SD)-type LAD with IgA antibodies reactive with the dermal side in ssIIF, which they designate as IgA EBA.1 |
doi_str_mv | 10.1001/jamadermatol.2021.0761 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2544460241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2781366</ama_id><sourcerecordid>2571136825</sourcerecordid><originalsourceid>FETCH-LOGICAL-a339t-2fd83e5acbfaf73e216c7faa61ed72e11f136805752227087ec2ff3eeff999ba3</originalsourceid><addsrcrecordid>eNpdkctOwzAQRS0EAgT8AAsUiQ2LpviR2O6yanlJFSABSxRNk3FJldjFThb9e1wKFcIbe-Rz74zmEnLB6JBRyq6X0EKFvoXONUNOORtSJdkeOeZM6lRSne3v3lIfkbMQljQeTWkm2CE5EhmTNJf6mLzf16Fzfj1IpjUsrAt1GCTP0H24BVr8rsBWyaNr0ZYNdL3HpLbJSz9voK0tJFO0AdLX9QqTWW0RfPKwGEezgBDwlBwYaAKe_dwn5O325nVyn86e7h4m41kKQoy6lJtKC8yhnBswSmAcvVQGQDKsFEfGDBNS01zlnHNFtcKSGyMQjRmNRnMQJ-Rq67vy7rPH0BVtHUpsGrDo-lDwPMsySXnGInr5D1263ts4XaQU2zTieaTkliq9C8GjKVa-bsGvC0aLTQbF3wyKTQbFJoMovPix7-ctVjvZ78YjcL4Fon73y5WOjaX4Amt7jZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2571136825</pqid></control><display><type>article</type><title>History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Hashimoto, Takashi ; Yamagami, Jun ; Zone, John J</creator><creatorcontrib>Hashimoto, Takashi ; Yamagami, Jun ; Zone, John J</creatorcontrib><description>In this issue of JAMA Dermatology, Becker et al1 report an extensive retrospective study of 300 patients who received diagnoses of IgA epidermolysis bullosa acquisita (EBA), IgG EBA, or linear IgA disease (LAD) at a single institution. They identified cohorts of 3 different autoimmune bullous diseases (AIBDs), including 222 cases of lamina lucida (LL)-type LAD with IgA autoantibodies reactive with the epidermal side in indirect immunofluorescence (IIF) using 1M sodium chloride–split normal human skin (ssIIF), which they designate as linear IgA bullous dermatosis (LABD), 57 cases of classical EBA with IgG autoantibodies to type VII collagen (COL7), and 21 cases of sublamina densa (SD)-type LAD with IgA antibodies reactive with the dermal side in ssIIF, which they designate as IgA EBA.1</description><identifier>ISSN: 2168-6068</identifier><identifier>EISSN: 2168-6084</identifier><identifier>DOI: 10.1001/jamadermatol.2021.0761</identifier><identifier>PMID: 34160568</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Autoimmune diseases ; Classification ; Humans ; Immunoglobulin A ; Linear IgA Bullous Dermatosis ; Medical diagnosis ; Pathogenesis ; Skin diseases ; Skin Diseases, Vesiculobullous - pathology</subject><ispartof>Archives of dermatology (1960), 2021-08, Vol.157 (8), p.907-909</ispartof><rights>Copyright American Medical Association Aug 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a339t-2fd83e5acbfaf73e216c7faa61ed72e11f136805752227087ec2ff3eeff999ba3</citedby><cites>FETCH-LOGICAL-a339t-2fd83e5acbfaf73e216c7faa61ed72e11f136805752227087ec2ff3eeff999ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamadermatology/articlepdf/10.1001/jamadermatol.2021.0761$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2021.0761$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,776,780,3327,27901,27902,76232,76235</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34160568$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hashimoto, Takashi</creatorcontrib><creatorcontrib>Yamagami, Jun</creatorcontrib><creatorcontrib>Zone, John J</creatorcontrib><title>History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease</title><title>Archives of dermatology (1960)</title><addtitle>JAMA Dermatol</addtitle><description>In this issue of JAMA Dermatology, Becker et al1 report an extensive retrospective study of 300 patients who received diagnoses of IgA epidermolysis bullosa acquisita (EBA), IgG EBA, or linear IgA disease (LAD) at a single institution. They identified cohorts of 3 different autoimmune bullous diseases (AIBDs), including 222 cases of lamina lucida (LL)-type LAD with IgA autoantibodies reactive with the epidermal side in indirect immunofluorescence (IIF) using 1M sodium chloride–split normal human skin (ssIIF), which they designate as linear IgA bullous dermatosis (LABD), 57 cases of classical EBA with IgG autoantibodies to type VII collagen (COL7), and 21 cases of sublamina densa (SD)-type LAD with IgA antibodies reactive with the dermal side in ssIIF, which they designate as IgA EBA.1</description><subject>Autoimmune diseases</subject><subject>Classification</subject><subject>Humans</subject><subject>Immunoglobulin A</subject><subject>Linear IgA Bullous Dermatosis</subject><subject>Medical diagnosis</subject><subject>Pathogenesis</subject><subject>Skin diseases</subject><subject>Skin Diseases, Vesiculobullous - pathology</subject><issn>2168-6068</issn><issn>2168-6084</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctOwzAQRS0EAgT8AAsUiQ2LpviR2O6yanlJFSABSxRNk3FJldjFThb9e1wKFcIbe-Rz74zmEnLB6JBRyq6X0EKFvoXONUNOORtSJdkeOeZM6lRSne3v3lIfkbMQljQeTWkm2CE5EhmTNJf6mLzf16Fzfj1IpjUsrAt1GCTP0H24BVr8rsBWyaNr0ZYNdL3HpLbJSz9voK0tJFO0AdLX9QqTWW0RfPKwGEezgBDwlBwYaAKe_dwn5O325nVyn86e7h4m41kKQoy6lJtKC8yhnBswSmAcvVQGQDKsFEfGDBNS01zlnHNFtcKSGyMQjRmNRnMQJ-Rq67vy7rPH0BVtHUpsGrDo-lDwPMsySXnGInr5D1263ts4XaQU2zTieaTkliq9C8GjKVa-bsGvC0aLTQbF3wyKTQbFJoMovPix7-ctVjvZ78YjcL4Fon73y5WOjaX4Amt7jZQ</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Hashimoto, Takashi</creator><creator>Yamagami, Jun</creator><creator>Zone, John J</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20210801</creationdate><title>History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease</title><author>Hashimoto, Takashi ; Yamagami, Jun ; Zone, John J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a339t-2fd83e5acbfaf73e216c7faa61ed72e11f136805752227087ec2ff3eeff999ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Autoimmune diseases</topic><topic>Classification</topic><topic>Humans</topic><topic>Immunoglobulin A</topic><topic>Linear IgA Bullous Dermatosis</topic><topic>Medical diagnosis</topic><topic>Pathogenesis</topic><topic>Skin diseases</topic><topic>Skin Diseases, Vesiculobullous - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hashimoto, Takashi</creatorcontrib><creatorcontrib>Yamagami, Jun</creatorcontrib><creatorcontrib>Zone, John J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of dermatology (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hashimoto, Takashi</au><au>Yamagami, Jun</au><au>Zone, John J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease</atitle><jtitle>Archives of dermatology (1960)</jtitle><addtitle>JAMA Dermatol</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>157</volume><issue>8</issue><spage>907</spage><epage>909</epage><pages>907-909</pages><issn>2168-6068</issn><eissn>2168-6084</eissn><abstract>In this issue of JAMA Dermatology, Becker et al1 report an extensive retrospective study of 300 patients who received diagnoses of IgA epidermolysis bullosa acquisita (EBA), IgG EBA, or linear IgA disease (LAD) at a single institution. They identified cohorts of 3 different autoimmune bullous diseases (AIBDs), including 222 cases of lamina lucida (LL)-type LAD with IgA autoantibodies reactive with the epidermal side in indirect immunofluorescence (IIF) using 1M sodium chloride–split normal human skin (ssIIF), which they designate as linear IgA bullous dermatosis (LABD), 57 cases of classical EBA with IgG autoantibodies to type VII collagen (COL7), and 21 cases of sublamina densa (SD)-type LAD with IgA antibodies reactive with the dermal side in ssIIF, which they designate as IgA EBA.1</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>34160568</pmid><doi>10.1001/jamadermatol.2021.0761</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-6068 |
ispartof | Archives of dermatology (1960), 2021-08, Vol.157 (8), p.907-909 |
issn | 2168-6068 2168-6084 |
language | eng |
recordid | cdi_proquest_miscellaneous_2544460241 |
source | MEDLINE; American Medical Association Journals |
subjects | Autoimmune diseases Classification Humans Immunoglobulin A Linear IgA Bullous Dermatosis Medical diagnosis Pathogenesis Skin diseases Skin Diseases, Vesiculobullous - pathology |
title | History, Diagnosis, Pathogenesis, and Nomenclature in Sublamina Densa-Type Linear IgA Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=History,%20Diagnosis,%20Pathogenesis,%20and%20Nomenclature%20in%20Sublamina%20Densa-Type%20Linear%20IgA%20Disease&rft.jtitle=Archives%20of%20dermatology%20(1960)&rft.au=Hashimoto,%20Takashi&rft.date=2021-08-01&rft.volume=157&rft.issue=8&rft.spage=907&rft.epage=909&rft.pages=907-909&rft.issn=2168-6068&rft.eissn=2168-6084&rft_id=info:doi/10.1001/jamadermatol.2021.0761&rft_dat=%3Cproquest_cross%3E2571136825%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2571136825&rft_id=info:pmid/34160568&rft_ama_id=2781366&rfr_iscdi=true |